These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Type I γ Phosphatidylinositol Phosphate 5-Kinase i5 Controls the Ubiquitination and Degradation of the Tumor Suppressor Mitogen-inducible Gene 6. Sun M; Cai J; Anderson RA; Sun Y J Biol Chem; 2016 Oct; 291(41):21461-21473. PubMed ID: 27557663 [TBL] [Abstract][Full Text] [Related]
4. The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations. Endo H; Okami J; Okuyama H; Nishizawa Y; Imamura F; Inoue M Oncogene; 2017 May; 36(20):2824-2834. PubMed ID: 27893711 [TBL] [Abstract][Full Text] [Related]
6. Exploring the interactions of EGFR with phosphorylated Mig6 by molecular dynamics simulations and MM-PBSA calculations. Zhang Y; Zheng QC J Theor Biol; 2018 Jun; 447():118-125. PubMed ID: 29574142 [TBL] [Abstract][Full Text] [Related]
7. Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations. Walsh AM; Lazzara MJ Integr Biol (Camb); 2014 Mar; 6(3):312-23. PubMed ID: 24445374 [TBL] [Abstract][Full Text] [Related]
8. The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6. Menezes SV; Kovacevic Z; Richardson DR J Biol Chem; 2019 Mar; 294(11):4045-4064. PubMed ID: 30679310 [TBL] [Abstract][Full Text] [Related]
9. Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells. Walsh AM; Lazzara MJ J Cell Sci; 2013 Oct; 126(Pt 19):4339-48. PubMed ID: 23868981 [TBL] [Abstract][Full Text] [Related]
10. Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6. Park E; Kim N; Ficarro SB; Zhang Y; Lee BI; Cho A; Kim K; Park AKJ; Park WY; Murray B; Meyerson M; Beroukhim R; Marto JA; Cho J; Eck MJ Nat Struct Mol Biol; 2015 Sep; 22(9):703-711. PubMed ID: 26280531 [TBL] [Abstract][Full Text] [Related]
11. Truncation, modification, and optimization of MIG6(segment 2) peptide to target lung cancer-related EGFR. Yu XD; Yang R; Leng CJ Comput Biol Chem; 2016 Apr; 61():251-7. PubMed ID: 26967626 [TBL] [Abstract][Full Text] [Related]
13. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma. Kang DH; Jung SS; Yeo MK; Lee DH; Yoo G; Cho SY; Oh IJ; Kim JO; Park HS; Chung C; Lee JE BMC Cancer; 2020 Jun; 20(1):571. PubMed ID: 32552717 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Zhang X; Pickin KA; Bose R; Jura N; Cole PA; Kuriyan J Nature; 2007 Nov; 450(7170):741-4. PubMed ID: 18046415 [TBL] [Abstract][Full Text] [Related]
15. Mutation of epidermal growth factor receptor is associated with MIG6 expression. Nagashima T; Ushikoshi-Nakayama R; Suenaga A; Ide K; Yumoto N; Naruo Y; Takahashi K; Saeki Y; Taiji M; Tanaka H; Tsai SF; Hatakeyama M FEBS J; 2009 Sep; 276(18):5239-51. PubMed ID: 19674104 [TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of mig6 reduces its inhibition of the epidermal growth factor receptor. Wang Z; Raines LL; Hooy RM; Roberson H; Leahy DJ; Cole PA ACS Chem Biol; 2013 Nov; 8(11):2372-6. PubMed ID: 24004111 [TBL] [Abstract][Full Text] [Related]
17. Understanding the MIG6-EGFR Signaling Axis in Lung Tumorigenesis. Izumchenko E; Sidransky D Cancer Discov; 2015 May; 5(5):472-4. PubMed ID: 25941338 [TBL] [Abstract][Full Text] [Related]
18. The Tumor Suppressor MIG6 Controls Mitotic Progression and the G2/M DNA Damage Checkpoint by Stabilizing the WEE1 Kinase. Sasaki M; Terabayashi T; Weiss SM; Ferby I Cell Rep; 2018 Jul; 24(5):1278-1289. PubMed ID: 30067982 [TBL] [Abstract][Full Text] [Related]
19. PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells. Siu A; Virtanen C; Jongstra J Oncotarget; 2011 Dec; 2(12):1134-44. PubMed ID: 22193779 [TBL] [Abstract][Full Text] [Related]
20. Conversion of MIG6 peptide from the nonbinder to binder of lung cancer-related EGFR by phosphorylation and cyclization. Li N; Wei M Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):1023-1028. PubMed ID: 27346601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]